Evaluation of the efficacy of Si-based agent in Rheumatoid Arthritis with complicating vestibular impairment
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent joint inflammation and progressive disability. Although current therapies have improved clinical outcomes, safer and more effective therapeutic approaches remain needed. Silicon (Si)-based agents have antioxidant and anti-inflammatory properties and have shown beneficial effects in several inflammatory disease models. Methods: We evaluated the effects of oral administration of a Si-based agent in a...